Poisons Act 1966 Regulation relating to the Schedule of Poisons and to labelling and packaging (1992-508) [GG No 112 of 4.9.1992] (NSW)

1992—No. 508

POISONS ACT 1966—REGULATION

(Relating to the Schedule of Poisons and to labelling and packaging)

NEW SOUTH WALES

[Published in Gazette No. 112 of 4 September 1992]

HIS Excellency the Governor, with the advice of the Executive Council, and in pursuance of the Poisons Acy 1966, has been pleased to make the Regulation set forth hereunder.

RON PHILLIPS

Minister for Health.

Commencement

1. This Regulation commences on 1st January, 1993.

Amendments

2. The Poisons Regulations are amended:

(a)	by omitting from Regulation 2 the definitions of “Child-resistant
closure”, “Immediate wrapper”, “Internal use” and “Paint” and

by inserting instead, respectively, the following definitions:

“Child-resistant closure” means:

(a)	in the case of a can—a lid of the design known as “double-tight” or “triple-tight”; or
(b)	in any other case—a closure which is resistant to opening by children and which:

(i) is specified and described in Part I of Schedule 3 to Therapeutic Goods Order No. 20 (as amended by Therapeutic Goods Order No. 33) under Part 2 of the Therapeutic Goods Act 1989 of the Commonwealth; or

(ii)  is of a design approved for the time being by the Director-General.

1992—No. 508

“Immediate wrapper” means:

(a)	metal foil, plastic foil, waxed paper or any other such material, not intended for consumption, used as a first wrapper for a single tablet, pastille, capsule, dressing or product unit; or
(b)	strip packaging when used in connection with some form of primary pack.

“Internal use” of a substance means administration:

(a) orally, except for topical use in the mouth; or

(b) for absorption and the production of a systemic effect:

(i)  by way of a body orifice other than the mouth; or

(ii)  parenterally, otherwise than by application to unbroken skin.

“Paint” , without limiting the ordinary meaning, includes any substance used or intended to be used for application as a colouring or protective coating to any surface, but does not include graphic material.

(b) by omitting subparagraph (d) of the definition of “Designated solvent” in Regulation 2 and by inserting instead the following subparagraph:

(d) methanol when included in Schedule 5 of the Poisons List; by inserting in Regulation 2 in alphabetical order the following definitions:

(c)

“External use” of a substance means application in the ears,

eyes or nose or to a body surface other than a surface in the
mouth, rectum, vagina, urethra or other body orifice.

“Graphic material” means the material which is to be deposited on other material by a graphic instrument during writing, drawing or other marking and includes the cores of pencils, school pastels and crayons, blackboard chalks, finger and showcard colours, poster paints and watercolour blocks.

“Topical use” means application of a substance for the

purpose of producing a localised effect on the surface of the
organ or within the tissue to which it is applied.

1992—No. 508

(d) by omitting Regulation 9 (c) and by inserting instead the following subparagraph:

(c) is securely closed and is capable of being securely reclosed, except:

(i)  when containing a preparation intended to be used on one occasion only; or

(ii)  when containing a poison included in Schedule 5 of the Poisons List (in which case the container must be capable of being reclosed, even if not securely); and

(e) by omitting from Regulation 10 (1) (b) the word “plastic”;

(f)	by inserting in Regulation 10 (4) (a) after the word “side” the words “or shoulder”;
(g)	by omitting Regulation 10AA (1) and by inserting instead the following paragraph:

(1) A person must not supply a substance that is specified or described in Column I of the Schedule to this Regulation in a bottle, jar or can of a capacity specified opposite the substance in Column II of that Schedule unless:

(a) the bottle, jar or can is fitted with a child-resistant closure; or

(b) the substance is supplied for therapeutic use only.

(h) by omitting the Schedule to Regulation 10AA and by inserting instead the following Schedule :

SCHEDULE

Column I Column II

ALKALINE SALTS when included in Schedule 5 of the Poisons List, when in liquid or gel form for use in dishwashing machines	5 litres or less
EUCALYPTUS OIL and liquid pre-
parations containing more than 50 per	200 millilitres or
cent of eucalyptus oil	less
HYDROCARBONS, LIQUID, when in- cluded in Schedule 5 of the Poisons List, when packed and labelled as kerosene, mineral turpentine, thinners, white petroleum spirit or dry-cleaning fluid	5 litres or less

1992—No. 508

SCHEDULE—Continued

HYDROCHLORIC ACID in aqueous solutions when included in Schedule 6 of the Poisons List, excluding preparations and admixtures	2.5 litres or less
MELALEUCA OIL (Tea-Tree Oil) when	200 millilitres or
included in Schedule 5 of the Poisons List	less
METHYLATED SPIRIT when included in Schedule 5 of the Poisons List, excluding preparations and admixtures	5 litres or less
METHYL SALICYLATE and liquid
preparations containing more than 50 per	200 millilitres or
cent of methyl salicylate	less
POTASSIUM HYDROXIDE as such in
bottles, jars or cans	2.5 litres or less
POTASSIUM HYDROXIDE in oven, hotplate or drain cleaners (other than those packed in pressurised aerosol containers) when included in Schedule 6 of the Poisons List	5 litres or less
SODIUM HYDROXIDE as such in
bottles, jars or cans	2.5 litres or less
SODIUM HYDROXIDE in oven, hotplate or drain cleaners (other than those packed in pressurised aerosol containers) when included in Schedule 6 of the Poisons List	5 litres or less
TURPENTINE OIL when included in
Schedule 5 of the Poisons List	5 litres or less

(i)  by omitting Regulation 10B (1) and by inserting instead the

following  paragraph : 

(1) This Regulation applies to the following substances for therapeutic use:

(a)	goods in solid dosage form which are specified in Schedule 1 to Therapeutic Goods Order No. 20 (as amended by Therapeutic Goods Order No. 33) under Part 2 of the Therapeutic Goods Act 1989 of the Commonwealth; and
(b)	goods in liquid preparations which are specified in Schedule 2 to Therapeutic Goods Order NO. 20 (as

1992—No. 508

amended by Therapeutic Goods Order No. 33) under Part 2 of the Therapeutic Goods Act 1989 of the Commonwealth.

(j) by inserting in Regulation 10B (2) (b) after the words “fitted with” the words “or incorporating”;

(k) by omitting the Schedule to Regulation 10B;

(l) by omitting Regulation 12 (1) (a)–(d) and by inserting instead the following subparagraphs:

(a) in the case of a selected container other than an ampoule, the words relating to that class of substance and the purpose for which it is to be used, as set forth in the following table:

Schedule Purpose Labelling Required

1 Any purpose POISON

2 Liquids for dermal POISON

use

2 Other than liquids for CAUTION

dermaluse

3	Any	purpose CAUTION
4	Any	purpose CAUTION
5	Any	purpose WARNING

6	For internal use CAUTION
6	Other than for POISON

internal use

7 Any purpose DANGEROUS

POISON

8 Any purpose CAUTION

(b) the name of the substance, being:

(i)  except as provided in subclause (ii), the approved name; or

(ii)  if the substance is a poison specified in the column headed “Poison” in the table to Regulation 14 (1) (b), either the name set out opposite the poison in the column headed “Name” in that table or the approved name; and

(c) the quantity, proportion or strength of the substance contained in the selected container or immediate wrapper; and

1992—No. 508

(d) the manufacturer’s name or registered brand; and

(e)	if the preparation is for treatment of animals only, the words “FOR ANIMAL TREATMENT ONLY”; and
(f)	in the case of ampoules (other than ampoules to which subparagraph (g) applies), the matter required by paragraphs (b), (c), (d) and (e); and

(g) in the case of plastic ampoules:

(i)  that are continuous with a strip of the same material which is labelled in accordance with the requirements of paragraphs (b), (c), (d) and (e); and

(ii) that are opened when detached from the strip,

the approved name or registered brand name of the substance and the quantity or strength of the substance.

(m) by omitting Regulation 12A (1) (a) and by inserting instead the following subparagraph:

(a) the labelling required for the poison, as shown in the table to Regulation 12 (1) (a);

(n)	by omitting from the column headed “Labelling Required” in the table to Regulation 13 (a) the word “POISON” shown opposite the matter “7” in the column headed “Schedule” and by inserting instead the words “DANGEROUS POISON”;
(o)	by omitting the table from Regulation 14 (1) (a) and by inserting instead the following table:
Schedule Purpose Labelling Required

1 For internal use POISON S1
USE STRICTLY AS
DIRECTED
KEEP OUT OF REACH
OF CHILDREN

1 Other than for POISON S1

internal use NOT TO BE TAKEN
KEEP OUT OF REACH
OF CHILDREN

2	Liquids for dermal	POISON S2
use	NOT TO BE TAKEN KEEP OUT OF REACH OF CHILDREN

1992—No. 508

2	Other than liquids for	CAUTION S2
dermal use	USE STRICTLY AS DIRECTED KEEP OUT OF REACH OF CHILDREN
3	Any purpose	CAUTION S3 USE STRICTLY AS DIRECTED KEEP OUT OF REACH
OF CHILDREN
4	Any purpose	CAUTION S4 SUPPLY WITHOUT PRESCRIPTION ILLEGAL KEEP OUT OF REACH
OF CHILDREN
5	Any purpose	WARNING KEEP OUT OF REACH
OF CHILDREN
6	For internal use	CAUTION USE STRICTLY AS DIRECTED KEEP OUT OF REACH OF CHILDREN

6 Other than for POISON

internal use	NOT TO BE TAKEN
KEEP OUT OF REACH
OF CHILDREN

7	Any purpose	DANGEROUS	POISON
S7

NOT TO BE TAKEN

KEEP OUT OF REACH

OF CHILDREN

8	Any purpose	CAUTION S8 SUPPLY WITHOUT PRESCRIPTION OR POSSESSION WITHOUT AUTHORITY ILLEGAL
KEEP OUT OF REACH OF CHILDREN

1992—No. 508

(p) by omitting from Regulation 14 (IA) (a) the matter “classified ‘(i)’ in Part 1” and by inserting instead the matter “classified ‘(o) or (p)’ in Part 1”;

(q) by inserting after Regulation 14 (1A) the following paragraph:
(1B) In the case of a poison containing a mixture of designated
solvents in a proportion exceeding 25 per cent of the total volume,
but where the proportion of any one such solvent does not exceed

25 per cent, the approved names of those solvents may be

expressed:

(a) to the extent that they are liquid hydrocarbons—as “liquid hydrocarbons”;

(b) to the extent that they are ketones—as “ketones”; or

(c) to the extent that they are other solvents—as “solvents” or “other solvents”.

(r) by inserting after Regulation 14 (2A) the following paragraph:
(2B) In the case of a poison, restricted substance or drug of
addiction which is packed for therapeutic use, the name required

by paragraph (1) (b) may appear in legible characters in a type

other than the type prescribed by Regulation 11 (c).

(s)	by inserting in Regulation 16 (2) after the word “ ‘Warning’ ” the words “or the words ‘Dangerous Poison’ ”;
(t)	by omitting Regulation 16 (3) and by inserting instead the following paragraphs:

(3) The word “Poison” or the word “Caution” or the word “Warning” or the words “Dangerous Poison”, as referred to in Regulation 14, must be written in red on a white background and surrounded by a red frame. That word or those words must form the first line of the principal label and no other marking may appear on the same line, other than a classification symbol identifying the Schedule of the Poisons List which applies to the preparation in the container to which the label is attached. The symbol may be printed outside the frame at the end of the line.

(3A) The word or words referred to in paragraph 3 (other than the word “Warning”) must be written in letters of a size not less than half the size of the largest lettering on the label. The lettering in the case of the word “Warning” must have a minimum height of 3 millimetres and, in any case, a height of not less than one quarter of the height of the largest lettering on the label.

(u) by omitting Regulation 16 (4) (e) and by inserting instead the following subparagraph:

(e) “Burns skin and throat”,

1992—No. 508

(v)  by inserting in Regulation 16 (4) after the word “ ‘Caution’ ” the words “or the word ‘Warning’ or the words ‘Dangerous Poison’ ”;

(w) by omitting from Regulation 16 (5) (a) the words “Except as provided in paragraph (6) of this regulation, where” and by inserting instead the word “If”;

(x) by omitting Regulation 16 (6);

(y) by omitting Regulation 18B (1) (a) and by inserting instead the following subparagraph:

(a) the word “WARNING” must be written in the manner required by Regulation 16 (3) and (3A);

(z) by omitting Regulation 20 (2) (h) and (i) and by inserting instead the following subparagraphs :

(h) in the case of a substance for oral use by a person aged 16 years or over, if the substance is specified and classified in Part 2 of Appendix G to these Regulations:

(i)  the warning statement specified in respect of that classification in Part 1 of that Appendix; and

(ii)  a symbol in the form of an open equilateral triangle not less than 4.5 millimetres high in bold print, coloured red and which immediately precedes the words of the warning statement; and

(i)  in the case of a substance specified and classified in Part 3 of Appendix G to these Regulations, the warning statement specified in respect of that classification in Part 1 of that Appendix.

(aa) by omitting from the list of substances in Regulation 31E the

following words: androisoxazole, androsterone,

boldenone,
clostebol,
dehydrotestosterone,
mestanolone,

testosterone except where Schedule Six of the Poisons List

applies,

trenbolone except where Schedule Six of the Poisons List

applies.

and by inserting in that list in alphabetical order the following
words:

1992—No. 508

anabolic steroidal agents not otherwise specified in this
Regulation when included in Schedule 4 of the Poisons List,

testosterone except when included in Schedule 6 of the Poisons

List.

(ab) by omitting from the list of substances in Regulation 33B (1) the word “codeine;”;

(ac) by omitting from Regulation 33B (3) the words “the substance

codeine or”;

(ad) by omitting from the list of substances in Regulation 38 (1) the

following:

demeton-O; demeton-S; phorate except where Schedule Six of the Poisons List applies;

and by inserting in that list in alphabetical order the following:

demeton;
phorate;

(ae) by omitting from Regulation 38 (1) the words “except where Schedule Six of the Poisons List applies” wherever occurring and by inserting instead the words “except when included in Schedule 6 of the Poisons List”;

(af) by omitting from Regulation 38 (1E) (b) the words “to which
Schedule Six of the Poisons List applies” and by inserting instead
the words “which is included in Schedule 5 of the Poisons List”;

(ag) by omitting Regulation 38 (1H) and by inserting instead the

following paragraph:

(1H) A person must not supply the substance maduramicin unless it is supplied as a preparation included in Schedule 6 of the Poisons List.

(ah) by omitting Regulation 39 (a) (ii) and (iii) and by inserting instead the following subclauses:

(ii) supplied in paint or graphic material; or

(iii)  a compound included in Schedule 4, 5 or 6 of the Poisons List;

(ai) by omitting Regulation 39 (b) and by inserting instead the following subparagraph:

(b) the person:

(i) is a pharmacist; and

(ii)  in supplying the compound, complies with the conditions of supply specified in Regulation 23A and the provisions of Regulations 23B, 23C and 23D

1992—No. 508

that would be applicable in respect of the supply of the compound if the compound were a substance included in Schedule 1 of the Poisons List; or

(aj) by inserting at the end of Regulation 39C (1) (b) the following

matter:

; or

(c) chlorinated rubber based paint containing less than 1 per cent of carbon tetrachloride.

(ak) by omitting Regulation 39D (1) and (1 A) and by inserting instead the following paragraph:

(1A) A person shall not supply paraquat except where the substance:

(a) is prepared for herbicide use;

(b) is supplied in a container or primary pack containing not less than 5 kilograms;

(c) is coloured blue or green; and
(d) contains a stenching agent.

(a1) by omitting from Regulation 39D (2) the words “Paragraphs (1) and (1A) shall” and by inserting instead the matter “This Regulation does”;

(am) by omitting from the list of substances in Regulation 40 (1) (a) the

following words:

orthotolidine except in solid state diagnostic reagents for

therapeutic use;

strychnine except where Schedule One or Four of the Poisons

List applies;

and by inserting in that list in alphabetical order the following

words:

ortho-tolidine except in solid state diagnostic reagents for

therapeutic use;

strychnine except when included in Schedule 4 of the Poisons

List;

(an) by omitting from the list of substances in Regulation 408 (1) the following words:

butanediol-bis-methanesulphonic acid ester;
hexachlorobenzene;
ivermectin except where Schedule Four or Six of the Poisons

List applies; metabromuron; prynachlor;

1992—No. 508

and by inserting in that list in alphabetical order the following

words:

HCB;

ivermectin except when included in Schedule 4 or 6 of the

Poisons List;
metobromuron;

(ao) by omitting from the list of substances in Regulation 41A (1) the following words:

prostaglandins for human therapeutic use except where

Schedule Four of the Poisons List applies;

and by inserting instead the following words:

prostaglandins for human therapeutic use except alprostadil,

gemeprost or prostaglandin F2 alpha;

(ap) by omitting from the list of substances in Regulation 42 (1) (a) the

following

amidopyrine;
broxaldine for internal human use;
broxyquinoline for internal human use;
chiniofon for internal human use;
chlorquinaldol for internal human use;
clioquinol for internal human use;
di-iodohydroxyquinoline for internal human use;
dipyrone except where Schedule Four of the Poisons List

words :

applies;

halquinol for internal human use;

prostaglandins for animal treatment except where Schedule

Four of the Poisons List applies;

1,1,1-trichloroethane and 1,1,2-trichloroethane for human

therapeutic use by inhalation;

and by inserting in that list in alphabetical order the following

words:

aminophenazone except when included in Schedule 4 of the

Poisons List;

clioquinol and other halogenated 8-hydroxyquinoline

derivatives for internal human use;

dipyrone except in preparations for animal treatment;

1,1,1-trichloroethane and 1,1,2-trichloroethane in pressurised

spray packs for therapeutic use;

(aq) by omitting from the list of substances in Regulation 42A (1) (a) the following words:

1992—No. 508

aflatoxins except in foods where specifically permitted under the Pure Food Act 1908;

asbestos to which Schedule Seven of the Poisons List applies; azathioprine except where Schedule Four of the Poisons List

applies;

busulphan except where Schedule Four of the Poisons List

applies;

chlorambucil except where Schedule Four of the Poisons List applies ;
cyclophosphamide except where Schedule Four of the Poisons

List applies;

melphalan except where Schedule Four of the Poisons List

applies;

methoxsalen except where Schedule Four of the Poisons List applies;

mustine except where Schedule Four of the Poisons List

applies;

oxymetholone except where Schedule Four of the Poisons List

applies;

phenacetin except where Schedule Four of the Poisons List

applies;

procarbazine except where Schedule Four of the Poisons List

applies;

stilboestrol except where Schedule Four of the Poisons List

applies;

thiotepa except where Schedule Four of the Poisons List applies;

treosulphan except where Schedule Four of the Poisons List

applies;

and by inserting in that list	in alphabetical order the following
words:

aflatoxins except in foods where specifically permitted under

the Food Act 1989;

asbestos when included in Schedule 7 of the Poisons List;
azathioprine except in preparations for therapeutic use;
busulphan except in preparations for therapeutic use;
chlorambucil except in preparations for therapeutic use;

cyclophosphamide except in preparations for therapeutic use;

melphalan except in preparations for therapeutic use;
methoxsalen except in preparations for therapeutic use;
mustine except in preparations for therapeutic use;
oxymetholone except in preparations for therapeutic use;
phenacetin when included in Schedule 7 of the Poisons List;
procarbazine except in preparations for therapeutic use;

1992—No. 508

stilboestrol except in preparations for therapeutic use;
thiotepa except in preparations for therapeutic use;
treosulphan when included in Schedule 7 of the Poisons List;

(ar) by omitting from the columns headed “Substance” “Form” and “Strength” in Regulation 43 (1) (f) the matter relating to fluorocarbons and chlorofluorocarbons and by inserting in alphabetical order in those columns, respectively, the following matter:

chlorofluorocarbons when	pressure	100 per cent
included in Schedule 3 of	spray
the Poisons List
fluorocarbons when included	pressure	100 per cent
in Schedule 3 of the Poisons	spray
List

(as) by inserting in alphabetical order in the list of substances in

Regulation 62A (1) the word “dexamphetamine;”;

(at) by omitting Appendices A and B and by inserting instead the following Appendices:

APPENDIX A

Reg. 14 (1) (e)

SUBSTANCES INCLUDED IN SCHEDULES 1, 2, 5, 6 AND 7 OF THE POISONS LIST WHICH ARE NOT REQUIRED TO BE LABELLED WITH DIRECTIONS FOR FIRST-AID ATTENTION IN CASE OF POISONING.

Allylisopropylacetylurea.
Aminophenazo ne.

Ammonia, including ammonium hydroxide, in substances

containing 5 per cent or less of ammonia.

Bacitracin.
Benzylpenicillin.

BHC in ear drops for animal. use containing 0.5 per cent or less

of BHC.

Buclosamide.
Buniodyl sodium.
Carbadox.

Carbaryl in preparations containing 2 per cent or less of

carbaryl.

1992—No. 508

Chlortetracycline.
Dipyrone.
Dithiazanine.
Erythromycin.
Flavophospholipol.
Haloxon.

Hydrochloric acid in substances containing 10 per cent or less

of hydrogen chloride.

Hygromycin.
Iodine in preparations containing 2.5 per cent or less of free

iodine. Maldison in preparations containing 2 per cent or less of

maldison.

Meclofenamic acid.
Narasin.
Neomycin.
Niclosamide.
Oleandomycin.

Ox y tetracycline.

Phenethicillin.
Phenoxymethylpenicillin.

Phenylene diamines and alkylated phenylene diamines in hair

dyes.

Procaine penicillin.
Progesterone.

Selenium sulphide in preparations containing 2.5 per cent or

less of selenium sulphide.

Streptomycin.
Sulphaquinoxaline.
Sulphonamides.

Sulphuric acid in fire extinguishers or in substances containing

10 per cent or less of sulphuric acid.

Testosterone. Tetracycline. Trenbolone. Triparanol. Tylosin.

Virginiamycin.

1992—No. 508

APPENDIX B

Reg. 14 (1) (f)

WARNING STATEMENTS
Part 1

POISONS REQUIRED TO BE LABELLED WITH A

WARNING STATEMENT AND THE CLASSIFICATION OF

THOSE POISONS

Poison Classification

Acetic acid in substances included in

Schedule 6 of the Poisons List	(a), (t), (w) and (y)
Acetic anyhydride in substances included in Schedule 6 of the Poisons List	(a), (t), (w) and (y)
Adrenaline in preparations for
inhalation	(n)

Alkaline salts when included in

Schedule 5 of the Poisons List	(b), (t) and (w)
Amines used as curing agents for epoxy resins	(t), (w), (y), (v) and
(x)
Anhydrides, organic, used as curing	(t), (w), (y), (v) and
agents for epoxy resins	(x)

Aniline except in substances

containing 1 per cent or less of

dine Antihistamine substances not otherwise (g), (t), (w) and (y)

specified in this Appendix except

astemnizole or terfenadine	(o) or (p)
Avermectin B1	(j), (t) and (w)
Bamipine	(o) or (p)
Benzene except:
(a)	in motor fuels containing 5 per cent or less of benzene; or
(b)	in other liquid hydrocarbons containing 1.5 per cent or less of benzene (f), (t) (w) and (z)

1992—No. 508

Benzoyl peroxide when included in

Schedule 5 of the Poisons List (t), (w) and (y)

Beryllium	(t), (w) and (y)
Brompheniramine	(o) or (p)
Camphor	(d)
Carbon disulphide	(f), (t), (w), (y) (z) and (ab)
Carbon tetrachloride	(f), (t), (w), (y) and (z)
Chlorcyclizine	(o) or (p)
Chlorinating compounds containing

more than 10 per cent of available

chlorine except in compressed

tablets containing 15 g or less of

trichloroisocyanuric acid (ah)

Chlorinating cornpounds in dry form containing 10 per cent or less of available chlorine	(e), (t), (w) and (ag)
Chlorinating compounds in liquid form	(e), (t), (w), (y) and (ag)
Chorpheniramine	(o) or (p)
Chromates of alkali metals and

ammonia, except in graphic

materials (t), (w) and (y)

Chromic acid (excluding its salts and

derivatives) except in alcohol

breathmeters containing 1 per cent

or less of chromic acid	(a), (t), (w) and (y)
Clemizole	(o) or (p)
Creosote	(t), (w), and (y)
Cyclizine	(o) or (p)
Cyclohexanone peroxide	(t), (w) and (x)
Cyproheptadine	(o) or (p)
Dichloroethylene	(t), (w) and (y)
Dichloroethyl ether	(t), (w) and (y)
Dichromates of alkali	metals and
ammonia, except in	graphic
materials	(t), (w) and (y)

1992—No. 508

Diethyltoluamide	(r)
Dimethydrinate	(o) or (p)
Dimethindene	(o) or (p)
Dimethyl sulphoxide:
(a) when packed and labelled for therapeutic use in animals; or	(s), (t), (w), (y) and
(x)
(b) when not packed and labelled for therapeutic use	(m), (t), (w), (y) and
(x)
Diphenhydramine	(o) or (p)
Diphenylpyraline	(o) or (p)
Doxylamine	(o) or (p)
Epoxy resins, liquid	(t), (w), (y), (v) and (x)
Ethyl bromide	(t), (w) and (y)
Ethylene glycol monoalkyl ethers	(t), (w) and (y)
Ethylene oxide	(t), (w) and (y)
Fluorides and silicofluorides including
bifluorides	(t) and (w)

Fluorocarbons and chlorofluorocarbons

included in Schedule 3 of the

Poisons List	(ae)
Formaldehyde except in substances containing 5 per cent or less of formaldehyde	(t), (w) and (y)
Formic acid (excluding its salts and

derivatives) except in substances

containing 30 per cent or less of

formic acid (t), (w) and (y)

Hexachlorophane in preparations for

skin cleansing purposes containing 3 per cent or less of hexachlorophane, except in preparations containing 0.1 per cent or less of hexachlorophane as a preservative (l)

Hydrocarbons, liquid, included in Schedule 5 of the Poisons List when packed and labelled as lighter

fluid (ae)

1992—No. 508

Hydrochloric acid (excluding its salts

and derivatives) in substances

containing:

(a)	30 per cent or less of hydrochloric
acid (t) and (w)

(b) more than 30 per cent of

hydrochloric acid (t), (w) and (y)

Hydrofluoric acid (excluding its salts

and derivatives)

(a) when included in Schedule 6 or 7 (ad), (i), (t), (w) and

of the Poisons List; or (y)

(b)	when included in Schedule 5 of
the Poisons List (a), (t) and (w)

Hydroquinone when included in

Schedule 2 of the Poisons List (af)

Hydrosilicofluoric acid (excluding its

salts and derivatives):

(a) when included in Schedule 6 or 7 (ad), (i), (t), (w) and

of the Poisons List; or (y)

(b)	when included in Schedule 5 of
the Poisons List (a), (t) and (w)

Isocyanates (free organic):

(a) when included in paint; or	(ai)
(b) other than in paint	(t), (w) and (y)

Isoprenaline in preparations for

inhalation except when included in

Schedule 4 of the Poisons List (n)

Ivermectin	(j)
Lopermide when included in

Schedule 3 of the Poisons List (q)

Mebhydrolin	(o) or (p)
Meclozine	(o) or (p)
Mepyramine	(o) or (p)
Metacresol sulphonic

acid-formaldehyde condensation

product	(t) and (w)
Methanol	(t), (w) and (y)

1992—No. 508

Me thdilazine (o) or (p)

Methyl chloride	(t),(w) and (y)
Methylene chloride	(ac),(t),(w) and (y)
Methylene chloride in degreasers,	(f),(h),(t),(w),(y)

decarbonisers and paint strippers and (aa)

Methyl ethyl ketone peroxide	(u)
1-( B -Methyl	sulphonamido

ethyl)-2-amino-3-N,N-diethylamino

benzene (t),(w) and (y)

Nicotine, except:

(a)	in substances containing 1 per cent or less of nicotine; or
(b) in tobacco in any form	(t) and (w)

Nitric acid (excluding its salts and

derivatives) (a),(t) and (w)

Nitrobenzene when included in

Schedule 6 of the Poisons List (t),(w) and (y)

Noradrenaline in preparations for inhalation	(n)
Orciprenaline in preparations for

inhalation (n)

Oxalic acid (excluding its salts and

derivatives) (a),(w) and (y)

Oxfendazole	(t) and (w)
Peracetic acid	(a),(t),(w) and (y)
Pheniramine	(o) or (p)
Phenol, cresol, creosote and other

homologues of phenol boiling below 220°C in substances containing more than 3 per cent by weight of

phenol, cresol, creosote and other
homologues of phenol boiling below

220°C (t),(w) and (x)

Phenylene diamines and alkylated

phenylene diamines not otherwise

specified in this Part of the

Appendix	:
(a) when used in hair dyes;	(k)

1992—No. 508

(b) when used other than in hair dyes (t) and (w)

ortho-Phenylphenol	(t) and (w)
Phenyltoloxamine	(o) or (p)
Phosphoric acid	(t) and (w)
Poly (hexamethylene biguanide)	(t),(w) and (y)
Potassium hydroxide (excluding its

salts and derivatives) when included

in Schedule 5 or 6 of the Poisons

List (a),(t) and (w)

Potassium sulphide in solid

preparations for metal treatment in

containers each containing 50 grams

or less of the preparation. (a),(t) and (w)

Promethazine	(o) or (p)
Quinine	(c)
Salbutamol in preparations for

inhalation (n)

Selenium compounds, except:

(a) when included in Schedule 4 of the Poisons List;

(b) in substances for therapeutic use;

(c)	in paints containing 0.1 per cent or less of selenium compounds calculated as a proportion of the non-volatile content of the paint; or
(d) in graphic materials	(t),(w) and (y)

Sodium chlorate except in substances

containing 50 per cent or less of

sodium chlorate (t) and (w)

Sodium hydroxide (excluding its salts

and derivatives) when included in

Schedule 5 or 6 of the Poisons List (a),(t) and (w)

Sodium sulphide in solid preparations

for metal treatment in containers

each containing 50 grams or less of

the preparation (a),(t) and (w)

1992—No. 508

Sulphamic acid (excluding its salts

and derivatives) (t) and (w)

Sulphuric acid (excluding its salts and derivatives) in substances containing more than 0.5 per cent by weight

of sulphuric acid except in fire

extinguishers (a),(t) and (w)

Terbutaline in preparations for

inhalation	(n)
Tetrachloroethane	(f) and (y)
Tetrachloroethylene, except:

(a) for therapeutic use;

(b) in preparations packed in

containers each containing 50 grams or less of the preparation; or

(c) in preparations containing 6 per

cent or less of tetrachloroethylene

where the substance is absorbed	(f),(h),(t),(w),(y)
into an inert solid material	and (aa)

Thenyldiamine	(o) or (p)
Toluene, except:
(a)	in substances containing 50 per cent or less by weight of toluene and xylene;
(b)	in  preparations packed in

containers each containing 50 grams or less of the preparation; or

(c) in paints (t),(w) and (y)

Toluene diamines when used in hair

dyes (k)

Trichloroethylene, except:

(a) for therapeutic use;

(b)	in paints containing 5 per cent or
less by weight of

trichloroethylene; or

(c)

in preparations packed in

containers each containing 50	(f),(t),(w),(x),(y)
grams or less of the preparation	and (z)

Trichlorophenol (t),(w) and (y)

1992—No. 508

Trifluoromethanesulphonic acid:

(a)	in preparations containing 10 per
cent or less of
trifluoromethanesulphonic acid; or (t),(w) and (y)
(b) in other preparations	(ad),(i),(t),(w) and (y)

Trimeprazine	(o) or (p)
Triprolidine	(o) or (p)
Xylene, except:

(a)	in substances containing 50 per cent or less by weight of toluene and xylene;
(b)	in preparations packed in

containers each containing 50 grams or less of the preparation; or

(c) in paints (t),(w) and (y)

Zinc chloride except in substances containing 5 per cent or less of zinc chloride (t) and (w)

Part 2

WARNING STATEMENTS TO BE MADE IN RESPECT OF

POISONS CLASSIFICATIONS

(Where more than one statement is required they may be

combined to form simple sentences if appropriate)

(a) Corrosive.
(b) Strongly alkaline.
(c) WARNING—May be fatal to children.
(d) Can be fatal to children if sucked or swallowed.
(e) WARNING—Vapour may be harmful.

(f) Vapour is harmful to health on prolonged exposure.

(g) May be fatal if inhaled, swallowed or absorbed through skin.

(h) Forms dangerous gas near radiators or naked flames.

(i)  Contact with eyes even for short periods can cause blindness.

1992—No. 508

(j)	WARNING—Skin contact may be dangerous. Take every precaution to avoid contact—wash off after spillage and after use.
(k)	WARNING—This product contains ingredients which may cause skin irritation to certain individuals. A preliminary test according to accompanying directions should be made before use. This product must not be used for dyeing eyelashes or eyebrows; to do so may be injurious to the eye.

(l) For external washing only. Rinse skin thoroughly after use.

(m) Not for therapeutic use.

(n)	Asthma sprays should only be part of an overall treatment plan. This should be regularly assessed with your doctor.
(o)	This medication (medicine) may cause drowsiness. If affected do not drive a vehicle or operate machinery. Avoid alcohol.
(p)	This medication (medicine) may cause drowsiness and may increase the effects of alcohol. If affected do not drive a motor vehicle or operate machinery.
(q)	Do not give to children under 12 years of age. Do not use beyond 48 hours or in pregnancy or lactation except on doctor’s advice.
(r)	WARNING—May be dangerous when used in large amounts or for long periods.
(s)	WARNING—Do not mix with other medication except on veterinarian’s advice.

(t) Avoid contact with eyes.

(u) Attacks eyes—protect eyes when using.

(v) Wear eye protection when mixing or using.
(w) Avoid contact with skin.
(x) Wear protective gloves when mixing or using.
(y) Avoid breathing dust (or) vapour (or) spray mist.

(z) Use only in a well ventilated area.

(aa) No smoking.
(ab) Keep away from heat, sparks and naked flames.
(ac) avoid contact with food.
(ad) Highly corrosive.

(ae) WARNING: Do not deliberately sniff this product.

Sniffing might harm or kill you.

1992—No. 508

(af) WARNING: If a pigmented spot or mole has recently become darker, changed colour, become enlarged or itchy, or bleeds, do not use this product, see your doctor immediately. Do not use on children. Do not use near the eyes. Mild irritation may occur; stop use if it becomes severe. If fading is not evident in three months, seek doctor’s advice.

(ag) Ensure adequate ventilation when using.
(ah) Highly reactive oxidising chlorine compound. May cause

fire or explosion or produce severe burns. Do not allow to get damp. Store under cover in a dry, clean, well-ventilated glace. Do not mix with other chemicals, especially other chlorine products. Explosion may result. Mix with water only. Do not add water to the product—add the product to water, but in case of fire, drench with water. Do not allow to come in contact with other chemicals, especially acids, or with combustible material such as paper, fabric, sawdust or kerosene. Avoid contact with skin, eyes and clothing and avoid breathing the dust or vapour.

(ai) Handling and usage of this paint must be carried out under well ventilated conditions that prevent inhalation of vapour and spray mist. Prevent skin contact by wearing impervious gloves. Wear a positive pressure air supplied full face respirator whilst spraying and until all spray mist has been effectively dispersed. Breathing of vapour or spray mist is harmful and. may cause lung irritation and allergic respiratory reaction.

(au) by omitting from Appendix D the following words:

Allobarbitone.
Androisoxazole
Androsterone.
Barbexaclone
Barbitone.

Barbituric acid derivatives not otherwise specified in this

appendix.

Bolde none

Clorazepic Acid.
Clostebol.
Dehydrotestosterone.
Dextropropoxyphene.
(-)-1-Dimethylamino-B,2-diphenylethane.
Ephedrine to which Schedule Four of the Poisons List applies.
N-ethylmphetamine.

1992—No. 508

Hexobarbitone.
Itobarbitone.
Mecloqualone.
Mestanolone.
Methohexitone.
Methylphenobarbitone.
Nealbarbitone.
Oxymetholone in preparations for therapeutic use.
Phenobarbitone.

Testosterone except where Schedule Six of the Poisons List

applies.

Thialbarbitone.
Thiopentone.

Trenbolone except where Schedule Six of the Poisons List

applies.

Vinbarbitone.
Vinylbitone.
and by inserting in that Appendix in alphabetical order the
following words:
Anabolic steroidal agents not otherwise specified in this

appendix when included in Schedule 4 of the Poisons List.

Barbiturates not otherwise specified in this appendix.
Benzodiazepine derivatives not otherwise specified in this

appendix. Clorazepate. Dextropropoxyphene when included in Schedule 4 of the

Poisons List.

Ephedrine when included in Schedule 4 of the Poisons List.
Midazolam.
Oxymetholone.
Testosterone except when included in Schedule 6 of the Poisons

List.

(av) by omitting from the columns headed “Substance” and

“Prescribed Quantity”, respectively, in Appendix E the following

matter:

Allobarbitone	50.0 grams
Androisoxzole	5.0 grams
Androsterone	5.0 grams
Barkxaclone	50.0 grams
Barbitone	50.0 grams
Boldenone	2.5 grams
Clostebol	2.0 grams
Dehydrotestosterone	2.5 grams

1992—No. 508

Ephedrine to which Schedule Four of the

Poisons List applies	5.0 grams
N-ethylamphetamine	1.0 gram
Hexobarbitone	50.0 grams
Itobarbitsne	50.0 grams
Mestanolone	5.0 grams
Methaqualone	50.0 grams
Methohexitone	50.0 grams
Methylphenobarbitone	50.0 grams
Nealbarbitone	50.0 grams
Oxymetholone in preparations for therapeutic
use	40.0 grams
Phenobarbitone	50.0 grams
Testosterone except where Schedule Six of
the Poisons List applies	20.0 grams
Thialbarbitone	50.0 grams
Thiopentone	50.0 grams
Trenbolone except where Schedule Six of the
Poisons List applies	5.0 grams
Vinbarbitone	50.0 grams
Vinylbitone	50.0 grams

and by inserting in those columns in alphabetical order the

following matter:

Alprazolam	0.25 gram
Anabolic steroidal agents not otherwise specified in this Appendix when included in Schedule 4 of the Poisons List	5.0 grams
Benzodiazepine derivatives not otherwise
specified in this Appendix	0.5 gram
Benzphetamine	5.0 grams
Bromazepam	5.0 grams
Buprenorphine	0.015 gram
Chlordhzegoxide	5.0 grams
Clobazam	2.5 grams
Clonazepam	0.5 gram
Clorazepate	3.0 grams
Dextropropoxyphene when included in
Schedule 4 of the Poisons List	15.0 grams
Diazepam	2.5 grams
Doxapram	2.0 grams
Ephedrine when included in Schedule 4 of
the Poisons List	5.0 grams
Flunitrazepam	0.5 grams

1992—No. 508

Flurazepam	10.0 grams
Lorazepam	1.0 gram
Mazindol	0.5 gram
Medazepam	2.5 grams
Meprobamate	100.0 grams
Methyprylone	40.0 grams
Midazolam	0.5 gram
Nalbuphine	0.5 gram
Nitrazepam	1.0 gram
Oxazepam	10.0 grams
Oxymetholone	40.0 grams
Paraldehyde	250 millilitres
Phentermine	10.0 grams
Prazepam	2.5 grams
Temazepam	5.0 grams
Testosterone except when included	in
Schedule 6 of the Poisons List	20.0 grams
Triazolam	0.05 gram
Zolazepam	2.5 grams

(aw) by omitting Appendix G and by inserting instead the following

Appendix:

APPENDIX G

Regs. 20 (2) (h) and (i)

WARNING STATMENTS

PART 1

WARNING STATEMENTS TO BE MADE IN RESPECT OF

SUBSTANCES CLASSIFIED UNDER PART 2 OR 3

Classification	Warning Statement
(a)	“This medication (medicine) may cause drowsiness. If affected do not drive a vehicle or operate machinery. Avoid alcohol. ”
(b)	‘‘This medication (medicine) may cause drowsiness and may increase the effects of alcohol. If affected do not drive a motor vehicle or operate machinery.”

1992—No. 508

(c) “WARNING—May be fatal to

children. ”

(d) “This medication (medicine) may affect mental alertness or co-ordination or both. If affected, do not drive a motor vehicle or operate machinery.”

PART 2

SUBSTANCES REQUIRED TO BE LABELLED WITH A WARNING STATEMENT AND THE CLASSIFICATION OF THOSE SUBSTANCES—SUBSTANCES FOR ORAL USE BY

A PERSON AGED 16 YEARS OR OVER.

Group	Substance	Classification
The following substances:	(d)
Amphetamine Chlorphentermine Dexamphetamine

Die thy lpropion

Ephedrine when included in

Schedule 4 of the Poisons List

Methylphenidate
Phentermine

Propylhexedrine

2	The following substances:	(a) or (b)
Alprazolam Amitriptyline Amylobarbitone Antihistamines not otherwise

specified in this Appendix
except Astemizole and
Terfenadine

Azatadine Baclofen Barbiturates not otherwise

specified in this Appendix

Benzodiazepine derivatives not

otherwise specified in this

Appendix

Benztropine
Bromazepam

1992—No. 508

Brompheniramine
Buclizine
Buprenorphine
Butobarbitone
Carbamazepine
Chloral Hydrate
Chlordiazepoxide
Chlormethiazole
Chlorpheniramine
Chlorpromazine
Clemastine
Clobazam
Clomipramine
Clonazepam
Clonidine
Clorazepate

Codeine except when included in

Schedule 2 of the Poisons

List.

Cyclizine
Cydobarbitone
Cycloserine
Cyproheptadine
Dantrolene
Desiprmine
Dexchlorpheniramine
Dextromormide
Dextropropoxyphene
Diazepam
Difenoxin
Dihydrocodeine
Dimenhydrinate
Dimethindene
Diphenhydramine
Diphenoxylate
Diphenylpyraline
Dothiegin
Doxapram
Doxepin
Doxylarnine
Droperidol
Ethchlorvynol
Ethylmorphine
Fenfluramine
Flunitrazepam

1992—No. 508

Fluphenazine
Flurazepm
Glutethimide
Haloperidol
Hydrocodone
Hydromorphone
Hydroxyzine
Imipramine
Lorazepam
Mazindol
Mebhydrolin
Meclozine
Medazepam
Meprobamate
Mepyramine

Methadone

Me thdilazine

Methocarbamol
Mianserin
Midazolam
Morphine
Nalbuphine
Nitrazepam
Nomethadone
Nortriptyline

Opium in any form except the

alkaloids Noscapine and
Papaverine

Oxazepam Oxycodone Papavereturn

Pen tazocine

Pentobarbitone
Pericyzine
Perphenzine
Pethidine
Phenelzine
Pheniramine
Phenoperidine
Phenyltoloxamine
Pholcodine
Pimozide
Pizotifen
Prazeapam
Prochlorperazine

Promazine
Promethazine
Protriptyline
Quinalbarbitone
Secbutobarbitone
Temazepam
Thenyldimine
Thiethylperazine
Thiopropazate
Thiopidazine
Thiothixene
Tranylcyprornine
Triazolam
Trifluoperazine
Trimeprazine
Trimipramine
Triprolidine

Valproate Sodium

PART 3

SUBSTANCES REQUIRED TO BE LABELLED WITH A WARNING STATEMENT AND THE CLASSIFICATION OF THOSE SUBSTANCES

Substance Classification

Quinine (c)

EXPLANATORY NOTE

Schedules One to Seven of the New South Wales Poisons List have been

amended to correspond (with minor variations) to Schedules 1 to 7 of the Standard
for the Uniform Scheduling of Drugs and Poisons (the SUSDP) of the National

Health and Medical Research Council.

Because of the terminology of the SUSDP and the altered requirements

concerning some of the substances concerned, it is necessary to make consequential the effect of providing that where a manufacturer of a poison, restricted substance or drug of addiction packs and labels such a product in accordance with the
amendments to certain regulations in the Poisons Regulations. The object of this
recommendations made in other parts of the SUSDP, that packing and labelling will
satisfy the relevant New South Wales requirements.